Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigonella Foenum-graecum Seed Extract in NAFLD
NCT02303314Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenugreek seed extract in non-alcoholic fatty liver disease (NAFLD), sponsored by Shiraz University of Medical Sciences. Started Nov 2014; status: completed.
02
Drugs
fenugreek seed extract
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02303314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303314.